| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen synthase activity, transferring glucose-1-phosphate | 4.75e-06 | 2 | 44 | 2 | GO:0061547 | |
| GeneOntologyMolecularFunction | parathyroid hormone receptor activity | 4.75e-06 | 2 | 44 | 2 | GO:0004991 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity | 1.42e-05 | 3 | 44 | 2 | GO:0004373 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.42e-05 | 3 | 44 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 3.64e-04 | 13 | 44 | 2 | GO:0035251 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 3.80e-04 | 439 | 44 | 6 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 3.80e-04 | 439 | 44 | 6 | GO:0019001 | |
| GeneOntologyMolecularFunction | D-glucose binding | 4.25e-04 | 14 | 44 | 2 | GO:0005536 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.25e-04 | 14 | 44 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.10e-04 | 18 | 44 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | GTPase activity | 8.87e-04 | 341 | 44 | 5 | GO:0003924 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 1.07e-03 | 22 | 44 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 1.07e-03 | 22 | 44 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.18e-03 | 211 | 44 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 1.27e-03 | 24 | 44 | 2 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 1.38e-03 | 25 | 44 | 2 | GO:0004114 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.41e-03 | 775 | 44 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 1.54e-03 | 386 | 44 | 5 | GO:0042578 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.61e-03 | 27 | 44 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | GTP binding | 1.74e-03 | 397 | 44 | 5 | GO:0005525 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.12e-03 | 31 | 44 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 2.22e-03 | 839 | 44 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 2.24e-03 | 840 | 44 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 2.24e-03 | 840 | 44 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.40e-03 | 33 | 44 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.66e-03 | 288 | 44 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 6.54e-03 | 55 | 44 | 2 | GO:0017046 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 8.31e-03 | 189 | 44 | 3 | GO:0004721 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 8.76e-03 | 1356 | 44 | 8 | GO:0060090 | |
| GeneOntologyCellularComponent | septin complex | 1.68e-08 | 14 | 44 | 4 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 1.68e-08 | 14 | 44 | 4 | GO:0005940 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 3.05e-08 | 16 | 44 | 4 | GO:0032156 | |
| GeneOntologyCellularComponent | cell division site | 2.40e-05 | 80 | 44 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | cell cortex | 1.20e-04 | 371 | 44 | 6 | GO:0005938 | |
| GeneOntologyCellularComponent | sperm annulus | 1.54e-04 | 9 | 44 | 2 | GO:0097227 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.54e-04 | 9 | 44 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.35e-04 | 11 | 44 | 2 | GO:0031094 | |
| Domain | Septin | 1.89e-08 | 13 | 44 | 4 | PF00735 | |
| Domain | G_SEPTIN_dom | 1.89e-08 | 13 | 44 | 4 | IPR030379 | |
| Domain | G_SEPTIN | 1.89e-08 | 13 | 44 | 4 | PS51719 | |
| Domain | Septin | 2.64e-08 | 14 | 44 | 4 | IPR016491 | |
| Domain | Glycogen_synth | 5.42e-06 | 2 | 44 | 2 | IPR008631 | |
| Domain | Glycogen_syn | 5.42e-06 | 2 | 44 | 2 | PF05693 | |
| Domain | InsP3_rcpt-bd | 1.62e-05 | 3 | 44 | 2 | IPR000493 | |
| Domain | RIH_assoc | 8.09e-05 | 6 | 44 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 8.09e-05 | 6 | 44 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 8.09e-05 | 6 | 44 | 2 | PF01365 | |
| Domain | RIH_dom | 8.09e-05 | 6 | 44 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.09e-05 | 6 | 44 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.09e-05 | 6 | 44 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 8.09e-05 | 6 | 44 | 2 | PF08709 | |
| Domain | - | 8.09e-05 | 6 | 44 | 2 | 1.25.10.30 | |
| Domain | GAF | 1.13e-04 | 7 | 44 | 2 | PF01590 | |
| Domain | GAF | 1.51e-04 | 8 | 44 | 2 | IPR003018 | |
| Domain | GAF | 1.51e-04 | 8 | 44 | 2 | SM00065 | |
| Domain | - | 1.93e-04 | 9 | 44 | 2 | 3.30.450.40 | |
| Domain | GAF_dom-like | 1.93e-04 | 9 | 44 | 2 | IPR029016 | |
| Domain | MIR | 2.41e-04 | 10 | 44 | 2 | PS50919 | |
| Domain | MIR | 2.41e-04 | 10 | 44 | 2 | PF02815 | |
| Domain | MIR | 2.41e-04 | 10 | 44 | 2 | SM00472 | |
| Domain | MIR_motif | 2.41e-04 | 10 | 44 | 2 | IPR016093 | |
| Domain | PDEase | 9.04e-04 | 19 | 44 | 2 | IPR023088 | |
| Domain | PDEase_I | 1.11e-03 | 21 | 44 | 2 | PF00233 | |
| Domain | PDEASE_I | 1.11e-03 | 21 | 44 | 2 | PS00126 | |
| Domain | PDEase_CS | 1.11e-03 | 21 | 44 | 2 | IPR023174 | |
| Domain | - | 1.22e-03 | 22 | 44 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.33e-03 | 23 | 44 | 2 | IPR002073 | |
| Domain | HDc | 1.45e-03 | 24 | 44 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 1.45e-03 | 24 | 44 | 2 | IPR003607 | |
| Domain | HormR | 1.57e-03 | 25 | 44 | 2 | SM00008 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.63e-03 | 99 | 44 | 3 | IPR029021 | |
| Domain | - | 1.66e-03 | 746 | 44 | 7 | 3.40.50.300 | |
| Domain | HRM | 1.97e-03 | 28 | 44 | 2 | PF02793 | |
| Domain | Ion_trans_dom | 2.44e-03 | 114 | 44 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.44e-03 | 114 | 44 | 3 | PF00520 | |
| Domain | GPCR_2_secretin-like_CS | 2.90e-03 | 34 | 44 | 2 | IPR017983 | |
| Domain | P-loop_NTPase | 3.42e-03 | 848 | 44 | 7 | IPR027417 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 4.00e-03 | 40 | 44 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 4.00e-03 | 40 | 44 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 4.00e-03 | 40 | 44 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 6.18e-03 | 50 | 44 | 2 | PS00650 | |
| Domain | 7tm_2 | 6.18e-03 | 50 | 44 | 2 | PF00002 | |
| Domain | GPCR_2-like | 8.80e-03 | 60 | 44 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 8.80e-03 | 60 | 44 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 9.09e-03 | 61 | 44 | 2 | PS50261 | |
| Domain | ZINC_FINGER_C2H2_2 | 9.21e-03 | 775 | 44 | 6 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 9.32e-03 | 777 | 44 | 6 | PS00028 | |
| Domain | Znf_C2H2-like | 1.04e-02 | 796 | 44 | 6 | IPR015880 | |
| Domain | Znf_C2H2 | 1.10e-02 | 805 | 44 | 6 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.12e-02 | 808 | 44 | 6 | SM00355 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 5.29e-05 | 5 | 33 | 2 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 7.92e-05 | 6 | 33 | 2 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS | 7.92e-05 | 6 | 33 | 2 | M47620 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.36e-04 | 10 | 33 | 2 | M47661 | |
| Pathway | REACTOME_CGMP_EFFECTS | 2.36e-04 | 10 | 33 | 2 | MM15054 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.88e-04 | 11 | 33 | 2 | M27466 | |
| Pathway | REACTOME_CA2_PATHWAY | 4.02e-04 | 62 | 33 | 3 | M27321 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47656 | |
| Pathway | WP_DISORDERS_OF_GALACTOSE_METABOLISM | 4.08e-04 | 13 | 33 | 2 | M45545 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 4.08e-04 | 13 | 33 | 2 | MM15015 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47696 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 4.08e-04 | 13 | 33 | 2 | MM14553 | |
| Pathway | REACTOME_GLYCOGEN_SYNTHESIS | 4.75e-04 | 14 | 33 | 2 | M27247 | |
| Pathway | REACTOME_CGMP_EFFECTS | 6.25e-04 | 16 | 33 | 2 | M902 | |
| Pathway | REACTOME_GLYCOGEN_STORAGE_DISEASES | 6.25e-04 | 16 | 33 | 2 | M27236 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 6.25e-04 | 16 | 33 | 2 | M26945 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 7.31e-04 | 76 | 33 | 3 | MM15051 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.86e-04 | 19 | 33 | 2 | M47760 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 8.86e-04 | 19 | 33 | 2 | M27423 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 8.86e-04 | 19 | 33 | 2 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 9.83e-04 | 20 | 33 | 2 | M47688 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.05e-03 | 86 | 33 | 3 | M916 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.09e-03 | 21 | 33 | 2 | M47689 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 1.19e-03 | 22 | 33 | 2 | M915 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.19e-03 | 22 | 33 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.19e-03 | 22 | 33 | 2 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.30e-03 | 23 | 33 | 2 | M47676 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.42e-03 | 24 | 33 | 2 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.42e-03 | 24 | 33 | 2 | M39643 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.54e-03 | 25 | 33 | 2 | M27857 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.54e-03 | 25 | 33 | 2 | MM14511 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.67e-03 | 26 | 33 | 2 | MM15502 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.80e-03 | 27 | 33 | 2 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.80e-03 | 27 | 33 | 2 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.93e-03 | 28 | 33 | 2 | M924 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.52e-03 | 32 | 33 | 2 | MM14983 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 2.84e-03 | 34 | 33 | 2 | MM15985 | |
| Pathway | REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM | 2.84e-03 | 34 | 33 | 2 | M27546 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 3.19e-03 | 36 | 33 | 2 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.19e-03 | 36 | 33 | 2 | M39831 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 3.47e-03 | 646 | 33 | 6 | MM14962 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.54e-03 | 38 | 33 | 2 | M27757 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 3.92e-03 | 40 | 33 | 2 | M39595 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 4.12e-03 | 41 | 33 | 2 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 4.32e-03 | 42 | 33 | 2 | M791 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 4.46e-03 | 143 | 33 | 3 | MM15055 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 4.64e-03 | 145 | 33 | 3 | M45512 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 4.73e-03 | 44 | 33 | 2 | M39845 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 4.73e-03 | 146 | 33 | 3 | M27288 | |
| Pathway | SIG_CHEMOTAXIS | 4.94e-03 | 45 | 33 | 2 | M5193 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 5.16e-03 | 46 | 33 | 2 | M8626 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 5.22e-03 | 702 | 33 | 6 | M746 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 5.79e-03 | 157 | 33 | 3 | M4904 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 6.07e-03 | 50 | 33 | 2 | M47951 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.55e-03 | 52 | 33 | 2 | M14171 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 6.80e-03 | 53 | 33 | 2 | MM15716 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.05e-03 | 54 | 33 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.05e-03 | 54 | 33 | 2 | M27460 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 7.05e-03 | 54 | 33 | 2 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 7.30e-03 | 55 | 33 | 2 | M47952 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 7.30e-03 | 55 | 33 | 2 | M39763 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 8.64e-03 | 60 | 33 | 2 | MM14964 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 8.92e-03 | 61 | 33 | 2 | MM15071 | |
| Pubmed | 4.01e-09 | 16 | 44 | 4 | 22575789 | ||
| Pubmed | Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission. | 1.58e-07 | 9 | 44 | 3 | 18809578 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 18539702 | ||
| Pubmed | PTH-receptors regulate norepinephrine release in human heart and kidney. | 1.56e-06 | 2 | 44 | 2 | 21756942 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22896038 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 1.56e-06 | 2 | 44 | 2 | 19120126 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 18708078 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15201137 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 1.56e-06 | 2 | 44 | 2 | 23582047 | |
| Pubmed | Androglobin, a chimeric mammalian globin, is required for male fertility. | 1.80e-06 | 19 | 44 | 3 | 35700329 | |
| Pubmed | 1.99e-06 | 163 | 44 | 5 | 16512683 | ||
| Pubmed | The imprinted Phlda2 gene regulates extraembryonic energy stores. | 2.86e-06 | 22 | 44 | 3 | 19884348 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 31979185 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10874040 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 9808793 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 4.69e-06 | 3 | 44 | 2 | 24904548 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17625225 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 20395455 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17327232 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17437169 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 23223241 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 25431134 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 16014380 | ||
| Pubmed | Human endothelial cell septins: SEPT11 is an interaction partner of SEPT5. | 4.69e-06 | 3 | 44 | 2 | 16767699 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 18194433 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17890015 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 18547250 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 36350267 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 32320395 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 4.69e-06 | 3 | 44 | 2 | 27777977 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 11413485 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 4.69e-06 | 3 | 44 | 2 | 23983250 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 12475938 | ||
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 4.69e-06 | 3 | 44 | 2 | 9858485 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 4.69e-06 | 3 | 44 | 2 | 17581770 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 20427533 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 4.69e-06 | 3 | 44 | 2 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 4.69e-06 | 3 | 44 | 2 | 1693919 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 19068129 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 23955339 | ||
| Pubmed | Characterising the dynamics of placental glycogen stores in the mouse. | 6.75e-06 | 29 | 44 | 3 | 32798765 | |
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 25215520 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 9.37e-06 | 4 | 44 | 2 | 21424589 | |
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 28419336 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 21818117 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 19120137 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 18280230 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 9.37e-06 | 4 | 44 | 2 | 35494252 | |
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 28615414 | ||
| Pubmed | Prenatal methamphetamine exposure causes dysfunction in glucose metabolism and low birthweight. | 9.37e-06 | 4 | 44 | 2 | 36353228 | |
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 10828023 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.08e-05 | 108 | 44 | 4 | 19531213 | |
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 11782428 | ||
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 24113571 | ||
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 19145258 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 1.56e-05 | 5 | 44 | 2 | 21568942 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.86e-05 | 440 | 44 | 6 | 34244565 | |
| Pubmed | 2.06e-05 | 127 | 44 | 4 | 30442766 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 2.25e-05 | 43 | 44 | 3 | 34672947 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 2.34e-05 | 6 | 44 | 2 | 21762810 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.34e-05 | 6 | 44 | 2 | 16844763 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.34e-05 | 6 | 44 | 2 | 25966694 | |
| Pubmed | Trps1 deficiency enlarges the proliferative zone of growth plate cartilage by upregulation of Pthrp. | 2.34e-05 | 6 | 44 | 2 | 18456591 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 14680475 | ||
| Pubmed | 3.27e-05 | 7 | 44 | 2 | 11860456 | ||
| Pubmed | Hepatic glycogen synthesis in the absence of glucokinase: the case of embryonic liver. | 3.27e-05 | 7 | 44 | 2 | 18165236 | |
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 3.27e-05 | 7 | 44 | 2 | 22495310 | |
| Pubmed | Septin 14 is involved in cortical neuronal migration via interaction with Septin 4. | 4.36e-05 | 8 | 44 | 2 | 20181826 | |
| Pubmed | 5.60e-05 | 9 | 44 | 2 | 25737585 | ||
| Pubmed | 6.99e-05 | 10 | 44 | 2 | 35200715 | ||
| Pubmed | 6.99e-05 | 10 | 44 | 2 | 15670850 | ||
| Pubmed | 7.70e-05 | 568 | 44 | 6 | 37774976 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 8.54e-05 | 11 | 44 | 2 | 27514653 | |
| Pubmed | 8.54e-05 | 11 | 44 | 2 | 20824138 | ||
| Pubmed | 1.02e-04 | 12 | 44 | 2 | 11832378 | ||
| Pubmed | 1.21e-04 | 13 | 44 | 2 | 8557689 | ||
| Pubmed | 1.41e-04 | 14 | 44 | 2 | 34630045 | ||
| Pubmed | 1.53e-04 | 403 | 44 | 5 | 30562941 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 1.63e-04 | 15 | 44 | 2 | 28578927 | |
| Pubmed | 2.06e-04 | 430 | 44 | 5 | 32581705 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 2.10e-04 | 17 | 44 | 2 | 27725084 | |
| Pubmed | 2.36e-04 | 18 | 44 | 2 | 31917811 | ||
| Pubmed | 3.24e-04 | 21 | 44 | 2 | 29659575 | ||
| Pubmed | Report of the sixth international workshop on human chromosome 3 mapping 1995. | 3.24e-04 | 21 | 44 | 2 | 8641130 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 3.24e-04 | 21 | 44 | 2 | 22216013 | |
| Pubmed | 3.24e-04 | 21 | 44 | 2 | 27740716 | ||
| Pubmed | 3.56e-04 | 22 | 44 | 2 | 11696558 | ||
| Pubmed | 3.92e-04 | 1084 | 44 | 7 | 11544199 | ||
| Pubmed | 4.24e-04 | 24 | 44 | 2 | 10843712 | ||
| Pubmed | 4.61e-04 | 25 | 44 | 2 | 17307970 | ||
| Pubmed | 4.99e-04 | 26 | 44 | 2 | 27542691 | ||
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 4.99e-04 | 26 | 44 | 2 | 15890332 | |
| Pubmed | 5.39e-04 | 125 | 44 | 3 | 29467281 | ||
| Pubmed | Phosphorylated tau interactome in the human Alzheimer's disease brain. | 5.39e-04 | 125 | 44 | 3 | 32812023 | |
| Pubmed | 6.21e-04 | 29 | 44 | 2 | 32123907 | ||
| Pubmed | 6.21e-04 | 29 | 44 | 2 | 26822703 | ||
| Interaction | ACAP3 interactions | 1.15e-07 | 21 | 44 | 4 | int:ACAP3 | |
| Interaction | SEPTIN12 interactions | 2.85e-07 | 26 | 44 | 4 | int:SEPTIN12 | |
| Interaction | SEPTIN14 interactions | 7.72e-07 | 33 | 44 | 4 | int:SEPTIN14 | |
| Interaction | SEPTIN4 interactions | 1.38e-06 | 38 | 44 | 4 | int:SEPTIN4 | |
| Interaction | SEPTIN1 interactions | 3.02e-06 | 46 | 44 | 4 | int:SEPTIN1 | |
| Interaction | SEPTIN5 interactions | 1.01e-05 | 62 | 44 | 4 | int:SEPTIN5 | |
| Interaction | SEPTIN3 interactions | 1.29e-05 | 66 | 44 | 4 | int:SEPTIN3 | |
| Interaction | CDC42EP4 interactions | 2.51e-05 | 78 | 44 | 4 | int:CDC42EP4 | |
| Interaction | SEPTIN8 interactions | 3.85e-05 | 87 | 44 | 4 | int:SEPTIN8 | |
| Interaction | SEPTIN6 interactions | 4.03e-05 | 88 | 44 | 4 | int:SEPTIN6 | |
| Interaction | SEPTIN11 interactions | 1.44e-04 | 122 | 44 | 4 | int:SEPTIN11 | |
| GeneFamily | Septins | 8.31e-09 | 13 | 35 | 4 | 732 | |
| GeneFamily | Parathyroid hormone receptors | 3.64e-06 | 2 | 35 | 2 | 270 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.09e-05 | 3 | 35 | 2 | 297 | |
| GeneFamily | Glycosyl transferases group 1 domain containing | 1.62e-04 | 10 | 35 | 2 | 427 | |
| GeneFamily | Phosphodiesterases | 9.78e-04 | 24 | 35 | 2 | 681 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.06e-03 | 25 | 35 | 2 | 504 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.18e-02 | 718 | 35 | 5 | 28 | |
| Drug | thiadiazolidinone | 2.41e-06 | 14 | 44 | 3 | CID000443041 | |
| Drug | AD-5075 | 3.01e-06 | 15 | 44 | 3 | CID000128440 | |
| Drug | BM 17.0744 | 3.71e-06 | 16 | 44 | 3 | CID009929731 | |
| Drug | JTT-501 | 4.49e-06 | 17 | 44 | 3 | CID000154000 | |
| Drug | v 405 | 1.09e-05 | 3 | 44 | 2 | CID003057126 | |
| Drug | nicotine iminium | 1.09e-05 | 3 | 44 | 2 | CID000000431 | |
| Drug | AC1L9IMU | 1.16e-05 | 23 | 44 | 3 | CID000445825 | |
| Drug | MCC-555 | 2.91e-05 | 31 | 44 | 3 | CID000204109 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.37e-05 | 192 | 44 | 5 | 6958_UP | |
| Drug | m-anisidine | 3.64e-05 | 5 | 44 | 2 | CID000010824 | |
| Drug | bp 16 | 3.64e-05 | 5 | 44 | 2 | CID000127325 | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; HL60; HT_HG-U133A | 3.81e-05 | 197 | 44 | 5 | 2479_DN | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 4.09e-05 | 200 | 44 | 5 | 6356_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.09e-05 | 200 | 44 | 5 | 5521_UP | |
| Drug | Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys | 5.45e-05 | 6 | 44 | 2 | CID003277749 | |
| Drug | phenyl glucuronide | 5.45e-05 | 6 | 44 | 2 | CID000087235 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 5.45e-05 | 6 | 44 | 2 | CID000082693 | |
| Drug | hexanediamine | 5.45e-05 | 6 | 44 | 2 | CID000134940 | |
| Drug | AC1L196J | 5.45e-05 | 6 | 44 | 2 | CID000000415 | |
| Drug | BAY R3401 | 5.45e-05 | 6 | 44 | 2 | CID009842599 | |
| Drug | 18-hydroxycorticosterone | 7.33e-05 | 42 | 44 | 3 | CID000011222 | |
| Drug | Chloropeptide | 7.62e-05 | 7 | 44 | 2 | CID000025565 | |
| Drug | NSC106398 | 7.62e-05 | 7 | 44 | 2 | CID000086763 | |
| Drug | kenpaullone | 7.87e-05 | 43 | 44 | 3 | CID000003820 | |
| Drug | gamma-glutamylhydroxamate | 1.30e-04 | 9 | 44 | 2 | CID000159636 | |
| Drug | alpha-chloroisocaproate | 1.30e-04 | 9 | 44 | 2 | CID000169071 | |
| Drug | H-47 | 1.63e-04 | 10 | 44 | 2 | CID003083866 | |
| Drug | UDP-pyridoxal | 1.63e-04 | 10 | 44 | 2 | CID000126789 | |
| Drug | Hg P | 1.65e-04 | 55 | 44 | 3 | CID000448530 | |
| Drug | phosphonopyruvate | 1.65e-04 | 55 | 44 | 3 | CID000439811 | |
| Drug | NSC625381 | 1.76e-04 | 145 | 44 | 4 | CID000002592 | |
| Drug | orthovanadate | 1.79e-04 | 435 | 44 | 6 | CID000061672 | |
| Drug | glycogen phosphorylase inhibitor | 1.99e-04 | 11 | 44 | 2 | CID010070301 | |
| Drug | AC1L1BIZ | 1.99e-04 | 11 | 44 | 2 | CID000001459 | |
| Drug | xestospongin C | 2.38e-04 | 12 | 44 | 2 | ctd:C511704 | |
| Drug | AC1LCVS1 | 2.38e-04 | 12 | 44 | 2 | CID000656959 | |
| Drug | prostaglandin F2 | 3.00e-04 | 306 | 44 | 5 | CID000000160 | |
| Drug | felodipine | 3.15e-04 | 169 | 44 | 4 | CID000003333 | |
| Drug | p-MeC | 3.27e-04 | 14 | 44 | 2 | CID000451929 | |
| Drug | AC1NRAG8 | 3.27e-04 | 14 | 44 | 2 | CID005287861 | |
| Drug | cytidine diphosphate-glucose | 3.77e-04 | 15 | 44 | 2 | CID000000292 | |
| Drug | M 16209 | 3.77e-04 | 15 | 44 | 2 | CID000164260 | |
| Drug | F-6b | 4.31e-04 | 16 | 44 | 2 | CID000004288 | |
| Drug | Sodium thioglucse | 4.31e-04 | 16 | 44 | 2 | CID000151466 | |
| Drug | butylethanolamine | 4.31e-04 | 16 | 44 | 2 | CID000249006 | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; HL60; HG-U133A | 4.72e-04 | 188 | 44 | 4 | 1622_DN | |
| Drug | mannosylamine | 4.87e-04 | 17 | 44 | 2 | CID000192844 | |
| Drug | proglycosyn | 4.87e-04 | 17 | 44 | 2 | CID000147052 | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 6721_DN | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; HL60; HT_HG-U133A | 5.01e-04 | 191 | 44 | 4 | 2393_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 1341_UP | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 4973_DN | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 2067_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; HL60; HG-U133A | 5.31e-04 | 194 | 44 | 4 | 1409_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 5.31e-04 | 194 | 44 | 4 | 5268_DN | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 5.31e-04 | 194 | 44 | 4 | 7352_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 5.31e-04 | 194 | 44 | 4 | 4169_DN | |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 2153_DN | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 3278_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 6303_UP | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 2966_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 4980_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 6926_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 4157_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 4105_UP | |
| Drug | sucrose-6-phosphate | 5.48e-04 | 18 | 44 | 2 | CID000644101 | |
| Drug | 1-GlcNAc | 5.48e-04 | 18 | 44 | 2 | CID000151446 | |
| Drug | pAPP | 5.48e-04 | 18 | 44 | 2 | CID000121930 | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 5279_DN | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 7265_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 3613_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 3637_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 2086_UP | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 2936_DN | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; HL60; HG-U133A | 5.52e-04 | 196 | 44 | 4 | 1729_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 7495_DN | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 6781_UP | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 2406_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 6757_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 2355_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 5.52e-04 | 196 | 44 | 4 | 3277_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 5791_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6611_DN | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6801_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6796_UP | |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 7459_UP | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 7411_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 3304_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 3216_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 7301_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 4745_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 7003_UP | |
| Drug | Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6296_DN | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 2267_UP | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 5415_DN | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; HL60; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 3043_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 2307_UP | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 2819_UP | |
| Drug | C75; Up 200; 10uM; PC3; HT_HG-U133A | 5.63e-04 | 197 | 44 | 4 | 6399_UP | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; PC3; HT_HG-U133A | 5.74e-04 | 198 | 44 | 4 | 5869_DN | |
| Disease | Anoxic Encephalopathy | 2.17e-06 | 2 | 44 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 2.17e-06 | 2 | 44 | 2 | C1527348 | |
| Disease | Anoxia of brain | 2.17e-06 | 2 | 44 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 2.17e-06 | 2 | 44 | 2 | C1140716 | |
| Disease | Lafora disease (implicated_via_orthology) | 1.30e-05 | 4 | 44 | 2 | DOID:3534 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.42e-04 | 12 | 44 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | behavioural inhibitory control measurement | 2.57e-04 | 16 | 44 | 2 | EFO_0008467 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.66e-04 | 19 | 44 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | hematocrit | 6.87e-04 | 1011 | 44 | 7 | EFO_0004348 | |
| Disease | Glycogen Storage Disease | 7.45e-04 | 27 | 44 | 2 | C0017919 | |
| Disease | phosphatidylcholine 38:4 measurement | 8.01e-04 | 28 | 44 | 2 | EFO_0010386 | |
| Disease | triacylglycerol 58:10 measurement | 1.18e-03 | 34 | 44 | 2 | EFO_0010437 | |
| Disease | sporadic amyotrophic lateral sclerosis | 1.20e-03 | 140 | 44 | 3 | EFO_0001357 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKCYHFVFQRYRLEH | 391 | Q9H6U8 | |
| RQIYHRYCMERASVH | 236 | P54840 | |
| NRLRKHLRAYHRCLY | 56 | Q9H2A7 | |
| YAVISQCIYRHRKDH | 1356 | Q6PL18 | |
| AYHFLRRYARCIHTN | 1261 | Q8WWL7 | |
| CRHRIRLGDSKSHYY | 311 | Q8TBN0 | |
| CYRVLRHSQQDYRKN | 556 | Q14571 | |
| HYHLREIIICTYRQA | 741 | Q9ULE6 | |
| TQHVYHKYRRRCLNE | 886 | Q6PKG0 | |
| CYRVLRHSQQDYRKN | 556 | Q14643 | |
| ERQARVRYYHQLSQH | 366 | P22083 | |
| KDSRQHYELEYRHRA | 116 | Q6UXY1 | |
| AAKCHLCRRYHASYR | 51 | Q8IVY1 | |
| GRSHRYHRKENLEYC | 131 | Q9BT17 | |
| NMYHRIRHSECIYRV | 416 | Q9Y233 | |
| KIYHLSYLHNCETRR | 221 | P35913 | |
| GRQCVEHYRLLHRYC | 611 | Q9UGL1 | |
| HQLRYYDHRVDTECK | 1791 | O95248 | |
| HRARHLYYCHLKERV | 156 | Q8N878 | |
| YCRKTIRHTAEYQEH | 206 | Q8NDY3 | |
| YYRRRHRHERTQTQK | 201 | Q9H819 | |
| FIQYRRERCHQKVHR | 441 | A8MQT2 | |
| RQIYHRYCMERAAAH | 236 | P13807 | |
| YRSHDHYQRQRVLQK | 1521 | Q5VV67 | |
| CHEHIYNQRRYMRSE | 321 | Q96LT7 | |
| YYNLLHCLRRDSHKI | 196 | P01236 | |
| YAKAQHVARRHYGCN | 406 | Q7Z2T5 | |
| REQTHTRHYELYRRC | 286 | Q9NVA2 | |
| KYDHQRYQHTVRVCG | 566 | Q96J65 | |
| HTRHYELYRRCKLEE | 291 | Q14141 | |
| ISRHYRRAHSCYKCR | 681 | Q9UHF7 | |
| ECYIQYHHSKIRNRG | 111 | Q8IY95 | |
| YDFNHKGHAYRRCDR | 136 | Q03431 | |
| QTHSRHYELYRRCKL | 291 | Q92599 | |
| REQTHTRHYELYRRC | 311 | Q9P0V9 | |
| IGYFRRLHCTRNYIH | 166 | P49190 | |
| VQRCQQAYMQYIHHR | 1761 | A7E2V4 | |
| YRHQRIHSLQKQYDC | 806 | P59923 | |
| SYDRNYRLVNHQRIH | 876 | P59923 | |
| VFNQKRYLACHRRSH | 251 | P17035 | |
| VFNSKRYVARHRRCH | 251 | Q7L2R6 | |
| RFLDKKHRNHYRVYN | 251 | Q6XPS3 | |
| KHRNHYRVYNLCSER | 256 | Q6XPS3 | |
| HCSYVAKYRRTLKRH | 726 | Q96DT7 | |
| NRHQSEREYIRYHAA | 4126 | Q5THJ4 | |
| YQRCHQHYDLSYRNK | 6 | P52179 |